Skip to main content

Together we are beating cancer

Donate now

Chemotherapy

Showing 12 out of 175 results
A chemotherapy line going into a patient's arm

A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy. A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.

by Cancer Research UK | News | 3 June 2018

3 June 2018

A scientist with a test tube

Aggressive breast cancers carrying a faulty BRCA gene responded better to a certain type of chemotherapy than standard treatment, according to a trial. Aggressive breast cancers carrying a faulty BRCA gene responded better to a certain type of chemotherapy than standard treatment, according to a trial.

by Cancer Research UK | News | 30 April 2018

30 April 2018

This entry is part 27 of 30 in the series Our milestones
  • Science & Technology
  • Health & Medicine

NCRI Cancer Conference 2016: Day 1 – lung cancer and yeast

We're in Liverpool for the annual National Cancer Research Institute (NCRI) Cancer Conference, sharing updates from the most exciting research on show. We're in Liverpool for the annual National Cancer Research Institute (NCRI) Cancer Conference, sharing updates from the most exciting research on show.

by Cancer Research UK | Analysis | 6 November 2016

6 November 2016

  • Science & Technology
  • Health & Medicine

Science Snaps: leukaemia cells are born to run

For this edition of Science Snaps we peer inside some bones, investigating how leukaemia cells get around and dodge treatment. For this edition of Science Snaps we peer inside some bones, investigating how leukaemia cells get around and dodge treatment.

by Emma Smith | Analysis | 20 October 2016

20 October 2016

This entry is part 17 of 30 in the series Science Snaps
Alan

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England. Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

by Peter Johnson | Analysis | 31 August 2016

31 August 2016

This entry is part 5 of 5 in the series Google Hangouts